HomeFilePharmacology

Pharmacology

View Category

Antiplatelet

ESC 2019 | THEMIS-PCI: Unlike in the Main Study, Here Ticagrelor Is Indeed Effective

This is a sub-study of the THEMIS presented during the ESC 2019 scientific sessions in Paris, and...
solaci -
Learn More
Antiplatelet

ESC 2019 | THEMIS: Ticagrelor in Diabetics with Stable Coronary Artery Disease

The use of ticagrelor in patients with stable coronary artery disease significantly reduces the rate of major...
solaci -
Learn More
Antiplatelet

ESC 2019 | POPULAR AGE: Good Old Clopidogrel Still Valid

According to this study, presented during the ESC 2019 scientific sessions, non-ST acute coronary syndrome (NSTE-ACS) patients...
solaci -
Learn More
Antithrombotic Anticoagulants

Do NOACs Result in Any Benefit in TAVR?

Courtesy of Dr. Carlos Fava. The need for anticoagulation after transcatheter aortic valve replacement (TAVR) is over 15%...
solaci -
Learn More
Other

Must Post MI Patients Use B Blockers for Life?

Long-term use of B blockers after myocardial infarction has been questioned for a while now; in fact,...
solaci -
Learn More
Other

Heart and Brain: Risk Factors, Atrial Fibrillation and Dementia

For decades, physiologists have known what cardiologists often forget: heart and brain communicate intensely in a healthy...
solaci -
Learn More
Antithrombotic Anticoagulants

PCI and Anticoagulation: What is the best strategy?

Most patients with atrial fibrillation require anticoagulation to reduce the risk of stroke or systemic embolization. Today,...
solaci -
Learn More
Other

Though Systolic BP Seems More Important, Diastolic BP Should Not Be Disregarded

Systolic hypertension is more often associated to cardiovascular events. However, diastolic blood pressure should not be disregarded,...
solaci -
Learn More